AAAAAA

   
Results: 1-11 |
Results: 11
Role of janus kinase 3 in mast cell-mediated innate immunity against gram-negative bacteria
Authors: Malaviya, R Navara, C Uckun, FM
Citation: R. Malaviya et al., Role of janus kinase 3 in mast cell-mediated innate immunity against gram-negative bacteria, IMMUNITY, 15(2), 2001, pp. 313-321
Expression of TEL-AML1 fusion transcripts and response to induction therapy in standard risk acute lymphoblastic leukemia
Authors: Uckun, FM Pallisgaard, N Hokland, P Navara, C Narla, R Gaynon, PS Sather, H Heerema, N
Citation: Fm. Uckun et al., Expression of TEL-AML1 fusion transcripts and response to induction therapy in standard risk acute lymphoblastic leukemia, LEUK LYMPH, 42(1-2), 2001, pp. 41-56
Chemosensitivity of TEL-AML1 fusion transcript positive acute lymphoblastic leukemia cells
Authors: Narla, RK Navara, C Sarquis, M Uckun, FM
Citation: Rk. Narla et al., Chemosensitivity of TEL-AML1 fusion transcript positive acute lymphoblastic leukemia cells, LEUK LYMPH, 41(5-6), 2001, pp. 615
X-ray structure, solution properties, and biological activity profile of vanadocene(IV) acetylacetonate complex, [VCp2(acac)](CF3SO3): a dual-function anti-cancer agent with anti-angiogenic and anti-mitotic properties
Authors: Ghosh, P Ghosh, S Navara, C Narla, RK Benyumov, A Uckun, FM
Citation: P. Ghosh et al., X-ray structure, solution properties, and biological activity profile of vanadocene(IV) acetylacetonate complex, [VCp2(acac)](CF3SO3): a dual-function anti-cancer agent with anti-angiogenic and anti-mitotic properties, J INORG BIO, 84(3-4), 2001, pp. 241-253
Bis(4,7-dimethyl-1,10-phenanthroline) sulfatooxovanadium(IV) as a novel apoptosis-inducing anticancer agent
Authors: Narla, RK Dong, YH D'Cruz, OJ Navara, C Uckun, FM
Citation: Rk. Narla et al., Bis(4,7-dimethyl-1,10-phenanthroline) sulfatooxovanadium(IV) as a novel apoptosis-inducing anticancer agent, CLIN CANC R, 6(4), 2000, pp. 1546-1556
Treatment of allergic asthma by targeting Janus kinase 3-dependent leukotriene synthesis in mast cells with 4-(3 ', 5 '-dibromo-4 '-hydroxyphenyl)amino-6,7-dimethoxyquinazoline (WHI-P97)
Authors: Malaviya, R Chen, CL Navara, C Malaviya, R Liu, XP Keenan, M Waurzyniak, B Uckun, FM
Citation: R. Malaviya et al., Treatment of allergic asthma by targeting Janus kinase 3-dependent leukotriene synthesis in mast cells with 4-(3 ', 5 '-dibromo-4 '-hydroxyphenyl)amino-6,7-dimethoxyquinazoline (WHI-P97), J PHARM EXP, 295(3), 2000, pp. 912-926
Expression of dominant-negative Ikaros isoforms in T-cell acute lymphoblastic leukemia
Authors: Sun, L Crotty, ML Sensel, M Sather, H Navara, C Nachman, J Steinherz, PG Gaynon, PS Seibel, N Mao, C Vassilev, A Reaman, GH Uckun, FM
Citation: L. Sun et al., Expression of dominant-negative Ikaros isoforms in T-cell acute lymphoblastic leukemia, CLIN CANC R, 5(8), 1999, pp. 2112-2120
Expression of aberrantly spliced oncogenic Ikaros isoforms in childhood acute lymphoblastic leukemia
Authors: Sun, L Goodman, PA Wood, CM Crotty, ML Sensel, M Sather, H Navara, C Nachman, J Steinherz, PG Gaynon, PS Seibel, N Vassilev, A Juran, BD Reaman, GH Uckun, FM
Citation: L. Sun et al., Expression of aberrantly spliced oncogenic Ikaros isoforms in childhood acute lymphoblastic leukemia, J CL ONCOL, 17(12), 1999, pp. 3753-3766
Pharmacokinetics and biologic activity of the novel mast cell inhibitor, 4-(3 '-hydroxyphenyl)amino-6,7-dimethoxyquinazoline in mice
Authors: Chen, CL Malaviya, R Navara, C Chen, H Bechard, B Mitcheltree, G Liu, XP Uckun, FM
Citation: Cl. Chen et al., Pharmacokinetics and biologic activity of the novel mast cell inhibitor, 4-(3 '-hydroxyphenyl)amino-6,7-dimethoxyquinazoline in mice, PHARM RES, 16(1), 1999, pp. 117-122
Expression of dominant-negative and mutant isoforms of the antileukemic transcription factor Ikaros in infant acute lymphoblastic leukemia
Authors: Sun, L Heerema, N Crotty, L Wu, X Navara, C Vassilev, A Sensel, M Reaman, GH Uckun, FM
Citation: L. Sun et al., Expression of dominant-negative and mutant isoforms of the antileukemic transcription factor Ikaros in infant acute lymphoblastic leukemia, P NAS US, 96(2), 1999, pp. 680-685
Bruton's tyrosine kinase as an inhibitor of the Fas/CD95 death-inducing signaling complex
Authors: Vassilev, A Ozer, Z Navara, C Mahajan, S Uckun, FM
Citation: A. Vassilev et al., Bruton's tyrosine kinase as an inhibitor of the Fas/CD95 death-inducing signaling complex, J BIOL CHEM, 274(3), 1999, pp. 1646-1656
Risultati: 1-11 |